| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 22 | 2020 | 1380 | 2.610 |
Why?
|
| Proteome | 11 | 2021 | 561 | 2.290 |
Why?
|
| Pancreatic Neoplasms | 29 | 2022 | 5061 | 2.260 |
Why?
|
| Colitis, Ulcerative | 8 | 2016 | 268 | 1.970 |
Why?
|
| Carcinoma, Pancreatic Ductal | 11 | 2021 | 1724 | 1.460 |
Why?
|
| Biomarkers, Tumor | 18 | 2021 | 10331 | 1.290 |
Why?
|
| Glycoproteins | 9 | 2018 | 747 | 1.030 |
Why?
|
| Pancreatic Juice | 3 | 2015 | 13 | 0.810 |
Why?
|
| Digestive System Diseases | 1 | 2020 | 35 | 0.720 |
Why?
|
| Proteins | 4 | 2020 | 1963 | 0.670 |
Why?
|
| Genes, Homeobox | 1 | 2019 | 147 | 0.670 |
Why?
|
| Mass Spectrometry | 10 | 2018 | 702 | 0.660 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 130 | 0.650 |
Why?
|
| Neoplasm Proteins | 7 | 2020 | 3230 | 0.630 |
Why?
|
| Diazooxonorleucine | 1 | 2017 | 1 | 0.630 |
Why?
|
| Cytoskeletal Proteins | 3 | 2012 | 492 | 0.620 |
Why?
|
| Colon | 5 | 2016 | 670 | 0.610 |
Why?
|
| Colorectal Neoplasms | 5 | 2016 | 3578 | 0.610 |
Why?
|
| Glycomics | 1 | 2016 | 27 | 0.590 |
Why?
|
| Glutamine | 1 | 2017 | 299 | 0.530 |
Why?
|
| Disease Progression | 9 | 2019 | 6682 | 0.520 |
Why?
|
| Phosphoproteins | 3 | 2012 | 1152 | 0.500 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2012 | 206 | 0.490 |
Why?
|
| Body Fluids | 1 | 2015 | 125 | 0.480 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2020 | 907 | 0.480 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 2359 | 0.480 |
Why?
|
| Adenocarcinoma | 10 | 2019 | 7789 | 0.470 |
Why?
|
| Pancreatitis, Chronic | 3 | 2011 | 116 | 0.470 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 1143 | 0.470 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 598 | 0.470 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2014 | 196 | 0.460 |
Why?
|
| Galectin 1 | 1 | 2012 | 20 | 0.430 |
Why?
|
| Rectum | 1 | 2014 | 467 | 0.430 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2012 | 621 | 0.420 |
Why?
|
| Deoxycytidine | 1 | 2017 | 1353 | 0.410 |
Why?
|
| Carrier Proteins | 4 | 2017 | 2022 | 0.390 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 622 | 0.380 |
Why?
|
| Cell Movement | 5 | 2014 | 2466 | 0.370 |
Why?
|
| Pancreatitis | 3 | 2014 | 267 | 0.370 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 270 | 0.370 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 1081 | 0.360 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2014 | 8873 | 0.360 |
Why?
|
| DNA Fingerprinting | 3 | 2005 | 167 | 0.350 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 1390 | 0.350 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2008 | 1756 | 0.340 |
Why?
|
| Peptidylprolyl Isomerase | 3 | 2014 | 73 | 0.330 |
Why?
|
| Cell Proliferation | 5 | 2019 | 7226 | 0.330 |
Why?
|
| Precancerous Conditions | 3 | 2016 | 1058 | 0.330 |
Why?
|
| Death-Associated Protein Kinases | 3 | 2020 | 22 | 0.320 |
Why?
|
| Cell Line, Tumor | 9 | 2020 | 14551 | 0.320 |
Why?
|
| Cell Adhesion Molecules | 2 | 2016 | 577 | 0.310 |
Why?
|
| Thy-1 Antigens | 2 | 2020 | 51 | 0.310 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 1546 | 0.310 |
Why?
|
| Glycosylation | 6 | 2021 | 213 | 0.300 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 159 | 0.300 |
Why?
|
| Humans | 54 | 2022 | 261506 | 0.300 |
Why?
|
| Genomic Instability | 2 | 2012 | 519 | 0.300 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2008 | 177 | 0.300 |
Why?
|
| Carcinoma in Situ | 2 | 2010 | 487 | 0.300 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 1823 | 0.280 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 973 | 0.280 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2019 | 2979 | 0.270 |
Why?
|
| Carcinoma | 3 | 2018 | 2578 | 0.260 |
Why?
|
| Immunohistochemistry | 10 | 2014 | 7548 | 0.260 |
Why?
|
| Fibroblasts | 1 | 2012 | 1682 | 0.250 |
Why?
|
| Oxidative Stress | 4 | 2021 | 1129 | 0.250 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2004 | 107 | 0.240 |
Why?
|
| HeLa Cells | 5 | 2014 | 1643 | 0.240 |
Why?
|
| ras Proteins | 1 | 2008 | 770 | 0.240 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2019 | 803 | 0.240 |
Why?
|
| Neoplasm Metastasis | 2 | 2012 | 5112 | 0.240 |
Why?
|
| MicroRNAs | 3 | 2016 | 2947 | 0.230 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5178 | 0.230 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 3343 | 0.220 |
Why?
|
| Survival Analysis | 1 | 2014 | 9180 | 0.220 |
Why?
|
| Down-Regulation | 4 | 2020 | 2074 | 0.210 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 2326 | 0.210 |
Why?
|
| Neutrophil Infiltration | 1 | 2022 | 109 | 0.210 |
Why?
|
| Tumor Microenvironment | 1 | 2012 | 2864 | 0.200 |
Why?
|
| ROC Curve | 4 | 2018 | 1183 | 0.200 |
Why?
|
| Glycation End Products, Advanced | 1 | 2021 | 31 | 0.200 |
Why?
|
| Carcinogenesis | 2 | 2019 | 1026 | 0.200 |
Why?
|
| Glyceraldehyde | 1 | 2021 | 32 | 0.200 |
Why?
|
| Myeloid Cells | 2 | 2020 | 269 | 0.190 |
Why?
|
| Phosphorylation | 5 | 2020 | 4804 | 0.190 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 3022 | 0.190 |
Why?
|
| Cell Survival | 4 | 2021 | 3045 | 0.190 |
Why?
|
| Repressor Proteins | 1 | 2008 | 1664 | 0.190 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2012 | 1489 | 0.190 |
Why?
|
| Aptamers, Nucleotide | 1 | 2020 | 62 | 0.190 |
Why?
|
| Transcription Factors | 1 | 2014 | 5270 | 0.180 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 3 | 2014 | 60 | 0.180 |
Why?
|
| Osteoblasts | 1 | 2002 | 370 | 0.180 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 6915 | 0.170 |
Why?
|
| HT29 Cells | 2 | 2020 | 159 | 0.170 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 334 | 0.170 |
Why?
|
| Stromal Cells | 2 | 2012 | 825 | 0.160 |
Why?
|
| Nitric Oxide | 1 | 2002 | 644 | 0.160 |
Why?
|
| Neutrophils | 1 | 2022 | 835 | 0.150 |
Why?
|
| Prognosis | 4 | 2019 | 21713 | 0.150 |
Why?
|
| Biopsy | 3 | 2016 | 3443 | 0.150 |
Why?
|
| Peptide Library | 1 | 2017 | 158 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 3 | 2012 | 3981 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 2488 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 669 | 0.140 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2019 | 560 | 0.140 |
Why?
|
| Signal Transduction | 7 | 2020 | 11965 | 0.140 |
Why?
|
| Animals | 13 | 2020 | 59536 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 717 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1493 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 336 | 0.130 |
Why?
|
| Cyst Fluid | 1 | 2015 | 21 | 0.130 |
Why?
|
| Tissue Array Analysis | 2 | 2014 | 760 | 0.130 |
Why?
|
| Early Detection of Cancer | 2 | 2015 | 1258 | 0.130 |
Why?
|
| Cell Cycle | 2 | 2019 | 2084 | 0.130 |
Why?
|
| Cell Line | 4 | 2014 | 5114 | 0.130 |
Why?
|
| Bile | 1 | 2015 | 81 | 0.130 |
Why?
|
| DNA Replication | 1 | 2019 | 744 | 0.130 |
Why?
|
| Epidermal Growth Factor | 2 | 2008 | 423 | 0.130 |
Why?
|
| Inflammation | 1 | 2005 | 2522 | 0.130 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2014 | 55 | 0.130 |
Why?
|
| Case-Control Studies | 4 | 2014 | 6100 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 4 | 2005 | 3203 | 0.130 |
Why?
|
| DNA | 1 | 2003 | 2693 | 0.120 |
Why?
|
| Plectin | 1 | 2013 | 4 | 0.120 |
Why?
|
| Pancreatic Cyst | 1 | 2015 | 107 | 0.120 |
Why?
|
| Drug Synergism | 1 | 2017 | 1313 | 0.120 |
Why?
|
| Blood Proteins | 2 | 2015 | 294 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2016 | 324 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2010 | 3536 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2016 | 1489 | 0.120 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2014 | 243 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2017 | 368 | 0.110 |
Why?
|
| Antigens, Neoplasm | 2 | 2017 | 1506 | 0.110 |
Why?
|
| Amino Acid Sequence | 5 | 2014 | 4233 | 0.110 |
Why?
|
| Mutation | 7 | 2019 | 15179 | 0.110 |
Why?
|
| Mice, Nude | 2 | 2012 | 4307 | 0.110 |
Why?
|
| Cell-Matrix Junctions | 1 | 2012 | 9 | 0.110 |
Why?
|
| Peptides | 2 | 2017 | 1479 | 0.110 |
Why?
|
| Sumoylation | 1 | 2013 | 84 | 0.110 |
Why?
|
| Tissue Fixation | 1 | 2013 | 136 | 0.110 |
Why?
|
| Area Under Curve | 2 | 2012 | 700 | 0.100 |
Why?
|
| DNA Methylation | 3 | 2016 | 2669 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2016 | 549 | 0.100 |
Why?
|
| Endopeptidases | 1 | 2013 | 220 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2013 | 185 | 0.100 |
Why?
|
| Biological Specimen Banks | 1 | 2011 | 76 | 0.100 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 6089 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 810 | 0.100 |
Why?
|
| Neoplastic Processes | 1 | 2010 | 15 | 0.100 |
Why?
|
| Myofibroblasts | 1 | 2012 | 133 | 0.100 |
Why?
|
| Exosomes | 1 | 2013 | 253 | 0.090 |
Why?
|
| Mucoproteins | 1 | 2010 | 25 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 2216 | 0.090 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 1082 | 0.090 |
Why?
|
| Osteopontin | 1 | 2010 | 148 | 0.090 |
Why?
|
| CA-19-9 Antigen | 1 | 2010 | 144 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 5395 | 0.090 |
Why?
|
| Models, Biological | 2 | 2012 | 3254 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6207 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2011 | 6009 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2020 | 1764 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 591 | 0.080 |
Why?
|
| Actins | 1 | 2012 | 608 | 0.080 |
Why?
|
| Breast Neoplasms | 3 | 2013 | 15694 | 0.080 |
Why?
|
| Catalytic Domain | 2 | 2011 | 303 | 0.080 |
Why?
|
| Oncogene Proteins | 1 | 2010 | 354 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2014 | 2450 | 0.080 |
Why?
|
| DNA Primers | 3 | 2013 | 1399 | 0.080 |
Why?
|
| Biomarkers | 3 | 2015 | 5047 | 0.080 |
Why?
|
| Apoptosis | 3 | 2021 | 7591 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2013 | 448 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 4892 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 1162 | 0.080 |
Why?
|
| Mice | 7 | 2016 | 34495 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2012 | 2803 | 0.070 |
Why?
|
| Plasminogen | 1 | 2007 | 26 | 0.070 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2007 | 55 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2008 | 5637 | 0.070 |
Why?
|
| Enzymes | 1 | 2007 | 64 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 769 | 0.070 |
Why?
|
| Young Adult | 2 | 2019 | 21445 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2013 | 886 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2006 | 108 | 0.070 |
Why?
|
| Pancreas | 4 | 2013 | 718 | 0.070 |
Why?
|
| Fibrinogen | 1 | 2007 | 205 | 0.070 |
Why?
|
| Male | 6 | 2019 | 123000 | 0.070 |
Why?
|
| Neoplasms | 1 | 2012 | 15193 | 0.070 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 275 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-crk | 1 | 2004 | 4 | 0.070 |
Why?
|
| Middle Aged | 5 | 2019 | 86204 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2016 | 2819 | 0.060 |
Why?
|
| Paxillin | 1 | 2004 | 30 | 0.060 |
Why?
|
| Adolescent | 2 | 2019 | 31252 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 329 | 0.060 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 362 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 1443 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2004 | 138 | 0.060 |
Why?
|
| COS Cells | 1 | 2004 | 377 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 14889 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1077 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 1555 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 2314 | 0.060 |
Why?
|
| Loss of Heterozygosity | 1 | 2005 | 602 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2004 | 549 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 359 | 0.060 |
Why?
|
| Time Factors | 2 | 2014 | 12926 | 0.060 |
Why?
|
| Chromatography, Liquid | 2 | 2017 | 342 | 0.060 |
Why?
|
| Female | 7 | 2019 | 141928 | 0.060 |
Why?
|
| Computational Biology | 3 | 2019 | 1271 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 2508 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 694 | 0.050 |
Why?
|
| Nitroprusside | 1 | 2002 | 48 | 0.050 |
Why?
|
| Cycloheximide | 1 | 2002 | 97 | 0.050 |
Why?
|
| Keratan Sulfate | 2 | 2012 | 11 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2020 | 5710 | 0.050 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2012 | 38 | 0.050 |
Why?
|
| Centrosome | 2 | 2013 | 95 | 0.050 |
Why?
|
| Lumican | 2 | 2012 | 22 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 198 | 0.050 |
Why?
|
| Kinetics | 1 | 2004 | 2049 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2002 | 207 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 1064 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 13658 | 0.050 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2012 | 66 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 367 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 1487 | 0.050 |
Why?
|
| Adult | 5 | 2019 | 77950 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2013 | 280 | 0.050 |
Why?
|
| Rats, Wistar | 1 | 2002 | 562 | 0.050 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2020 | 25 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2020 | 39 | 0.050 |
Why?
|
| Phosphoserine | 1 | 2020 | 107 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2002 | 553 | 0.050 |
Why?
|
| Protein Binding | 2 | 2020 | 3438 | 0.050 |
Why?
|
| Aged | 3 | 2019 | 70117 | 0.050 |
Why?
|
| Skull | 1 | 2002 | 231 | 0.050 |
Why?
|
| Risk Factors | 2 | 2016 | 17523 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2020 | 145 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 2232 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 29902 | 0.040 |
Why?
|
| Biodiversity | 1 | 2019 | 91 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 1547 | 0.040 |
Why?
|
| Shock, Septic | 1 | 2020 | 181 | 0.040 |
Why?
|
| Werner Syndrome | 1 | 1997 | 12 | 0.040 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 1997 | 41 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2002 | 1338 | 0.040 |
Why?
|
| Mutagens | 1 | 1997 | 187 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 1998 | 575 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2019 | 37905 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2016 | 72 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 538 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 1995 | 36 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2020 | 874 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2016 | 158 | 0.030 |
Why?
|
| Protein Phosphatase 2 | 1 | 2016 | 88 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1997 | 434 | 0.030 |
Why?
|
| Oncogenes | 1 | 2018 | 673 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 168 | 0.030 |
Why?
|
| Heterozygote | 1 | 1997 | 1020 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 1538 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 4971 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 1265 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 363 | 0.030 |
Why?
|
| Mucin 5AC | 1 | 2014 | 75 | 0.030 |
Why?
|
| Transfection | 2 | 2011 | 2944 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 14289 | 0.030 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2014 | 222 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2014 | 153 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 4744 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2018 | 731 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 223 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 252 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 5539 | 0.030 |
Why?
|
| Rats | 1 | 2002 | 6086 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 430 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 624 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 1029 | 0.030 |
Why?
|
| Colitis | 1 | 2016 | 340 | 0.030 |
Why?
|
| Genes, ras | 1 | 1995 | 667 | 0.030 |
Why?
|
| Gelsolin | 1 | 2012 | 14 | 0.030 |
Why?
|
| Exonucleases | 1 | 2012 | 51 | 0.030 |
Why?
|
| Peptide Mapping | 1 | 2012 | 114 | 0.030 |
Why?
|
| Versicans | 1 | 2011 | 28 | 0.030 |
Why?
|
| Chromosomal Instability | 1 | 2013 | 233 | 0.030 |
Why?
|
| Exoribonucleases | 1 | 2012 | 42 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 251 | 0.030 |
Why?
|
| Proto-Oncogenes | 2 | 2006 | 202 | 0.030 |
Why?
|
| Acinar Cells | 1 | 2011 | 53 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 945 | 0.030 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2011 | 76 | 0.030 |
Why?
|
| Software | 1 | 2019 | 1321 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2011 | 105 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 644 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2012 | 143 | 0.020 |
Why?
|
| Diet | 1 | 2019 | 1440 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2013 | 576 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 260 | 0.020 |
Why?
|
| Adipokines | 1 | 2011 | 96 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 221 | 0.020 |
Why?
|
| DNA Damage | 1 | 1998 | 1954 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 162 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 429 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 323 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 315 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 1519 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2015 | 1226 | 0.020 |
Why?
|
| Serine | 1 | 2011 | 388 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2012 | 691 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 2307 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 6942 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 1053 | 0.020 |
Why?
|
| Contrast Media | 1 | 2015 | 1472 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 3101 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1819 | 0.020 |
Why?
|
| Collagen | 1 | 2011 | 752 | 0.020 |
Why?
|
| Pedigree | 2 | 2006 | 1890 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1995 | 830 | 0.020 |
Why?
|
| Actinin | 1 | 2006 | 21 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 3033 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 3890 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 2173 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 1863 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 568 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2012 | 1271 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 6150 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2011 | 1620 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 9244 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2006 | 267 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1516 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 5159 | 0.010 |
Why?
|
| Base Sequence | 2 | 1998 | 4917 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 7551 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 7702 | 0.010 |
Why?
|
| Werner Syndrome Helicase | 1 | 1997 | 12 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1998 | 218 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1998 | 220 | 0.010 |
Why?
|
| Exodeoxyribonucleases | 1 | 1997 | 104 | 0.010 |
Why?
|
| RecQ Helicases | 1 | 1997 | 102 | 0.010 |
Why?
|
| Homozygote | 1 | 1997 | 717 | 0.010 |
Why?
|
| DNA Probes | 1 | 1995 | 217 | 0.010 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 1995 | 31 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1995 | 331 | 0.010 |
Why?
|
| Point Mutation | 1 | 1995 | 769 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1997 | 1294 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 1995 | 987 | 0.010 |
Why?
|
| DNA Repair | 1 | 1998 | 1872 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 4938 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 6295 | 0.000 |
Why?
|